BWXT
BWX Technologies, Inc.
Next earnings Aug 3, 2026 (after close) · consensus $1.07 EPS, $921M rev
Last earnings +0.2% on 2026-05-04
$191.06
▲ +0.96%$191.06▲ +34.18%
over 1Y
L $135.69H $238.10
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+1.0%
1W-6.7%
1M+2.0%
3M-11.0%
YTD+5.4%
1Y+34.2%
Hold
Conviction
Horizon
Long (>12mo)
Street · 22 analysts
Buy
Mission-critical nuclear/defense supplier with 18% growth and 27% ROE, but a 57x P/E and rising leverage cap the near-term upside.
P/E (FY diluted EPS $3.58) 57.4 · FY2025
The read
Middling fundamentals and a rich price (~29% above fair value) leave little margin of safety — a wait-and-see.
BWX Technologies is a sole-source supplier of nuclear components and fuel for U.S. Navy submarines and aircraft carriers, plus DOE site services and a growing medical-radioisotope business. The franchise is exceptionally defensible: ~68% of FY2025 revenue came from U.S. Government contracts and management states it 'has not been negatively impacted by federal budget reductions to date.' Operationally, FY2025 was strong — revenue grew 18.3% to $3.20B, net income rose 16.7% to $329M, diluted EPS climbed 16.6% to $3.58, and ROE is an impressive 26.7%. Revenue has compounded steadily from $2.12B in FY2021.
The balance sheet warrants attention. Total liabilities jumped 69.8% and long-term debt nearly doubled (+93.3%) to $2.02B, pushing liabilities/equity to 2.47x — elevated, though cash also surged to $500M and current assets ($1.56B) comfortably cover current liabilities ($672M). The debt-funded asset growth (+48.8%) appears tied to capacity expansion and the acquisition/investment strategy management describes. Operating cash flow of $480M (+17.5%) and a covered dividend ($92.5M) support the capital structure.
Is BWXT a buy? The one-page verdict, explained →
The options angle
model · matches our verdictCovered call~90d expiry
- Long 100 shares @ ~191.06
- Short call 200 @ ~11.30 est
debit $17,976max +$2,024max −$17,975BE 179.76
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $2.12B | $2.23B | $2.50B | $2.70B | $3.20B |
| Gross profit | — | — | — | — | — |
| Operating income | $346M | $349M | $383M | $381M | $404M |
| Net income | $306M | $238M | $246M | $282M | $329M |
| Diluted EPS | $3.24 | $2.60 | $2.68 | $3.07 | $3.58 |
| Net margin | 14.4% | 10.7% | 9.8% | 10.4% | 10.3% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$19.0B
EV / EBITDA37.0
EV / Sales5.9
EV / FCF64.4
P / FCF59.3
PEG (trailing)3.20
Earnings yield1.9%
FCF yield1.7%
Quality & risk
ROIC (est.)9.8%
Free cash flow$295M
Total debt$2.02B
Net cash-$1.52B
Altman Z-Score5.59 safe
Piotroski F-Score5/8
Capital returns
Buyback yield0.2%
Dividend yield (est.)0.5%
Shareholder yield0.7%
Shares Δ YoY-0.0%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
Recent filings
all on EDGAR ↗4Period ending 2026-07-012026-07-02open ↗4Period ending 2026-07-012026-07-02open ↗4Period ending 2026-06-052026-06-09open ↗4Period ending 2026-06-052026-06-09open ↗4Period ending 2026-06-052026-06-09open ↗4Period ending 2026-06-052026-06-09open ↗4Period ending 2026-06-052026-06-09open ↗4Period ending 2026-06-052026-06-09open ↗4Period ending 2026-06-052026-06-09open ↗4Period ending 2026-06-052026-06-09open ↗SDFiling2026-05-27open ↗4Period ending 2026-05-122026-05-12open ↗
Frequently asked
- Is BWX Technologies, Inc. (BWXT) a buy?
- BWXT currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Mission-critical nuclear/defense supplier with 18% growth and 27% ROE, but a 57x P/E and rising leverage cap the near-term upside.
- What is BWXT's fair value?
- A Modified-Graham model based on BWXT's SEC fundamentals estimates a fair value of about $136.04. It is an estimate from reported earnings, not a price target.
- Is BWXT overvalued or undervalued?
- Against a Modified-Graham fair-value estimate, BWXT currently appears overvalued relative to its SEC-grounded earnings power.
- What is BWX Technologies, Inc.'s quality score?
- BWXT scores 68.23705866082283/100 (grade B-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001486957, latest 10-Q filed 2026-05-04) · EODHD · Proprietary analysis · as of 6/21/2026, 8:42:29 PM.
About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:42 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.